Showing results (111-120 of 128) with videos related to
Sort By:
Pageof 13
Toxicology and Applied Pharmacology|August 17, 1999
Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathwaysA Barchowsky, R R Roussel, L R Klei, et al.Diabetes & Metabolism|November 2, 2019
Performance of a selective screening strategy for diagnosis of hyperglycaemia in pregnancy as defined by IADPSG/WHO criteriaE Cosson, E Vicaut, D Sandre-Banon, et al.Diabetes & Metabolism|November 21, 2017
Morning administration of 0.4U/kg/day insulin glargine 300U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100U/mL in type 1 diabetesT S Bailey, J Pettus, R Roussel, et al.Diabetes & Metabolism|April 8, 2020
Relationship between renal capacity to reabsorb glucose and renal status in patients with diabetesO Matar, L Potier, Y Abouleka, et al.Diabetes & Metabolism|June 13, 2016
T-cadherin gene variants are associated with type 2 diabetes and the Fatty Liver Index in the French populationA Nicolas, R Aubert, N Bellili-Muñoz, et al.Diabetes & Metabolism|December 4, 2018
Early screening for gestational diabetes mellitus is not associated with improved pregnancy outcomes: an observational study including 9795 womenE Cosson, E Vicaut, D Sandre-Banon, et al.Military Medicine|May 14, 2008
Regional methamphetamine use among U.S. Army personnel stationed in the continental United States and Hawaii: a six-year retrospective study (2000-2005)Benjamin W Lacy, Thomas F Ditzler, Raymond S Wilson, et al.Diabetes & Metabolism|December 10, 2019
SGLT2 inhibition increases serum copeptin in young adults with type 1 diabetesY Lytvyn, P Bjornstad, A Katz, et al.Diabetologia|December 4, 2010
Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective studyN Cheurfa, G M Brenner, A F Reis, et al.Diabetes & Metabolism|June 27, 2016
Sex hormone levels are not associated with progression of renal disease in male patients with T2DME Feigerlová, P-J Saulnier, P Gourdy, et al.Pageof 13